Compare RXT & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXT | WGS |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1300 |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | N/A |
| Metric | RXT | WGS |
|---|---|---|
| Price | $4.71 | $52.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $1.71 | ★ $120.71 |
| AVG Volume (30 Days) | ★ 36.7M | 1.4M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.13 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $2,685,700,000.00 | N/A |
| Revenue This Year | N/A | $29.98 |
| Revenue Next Year | $1.35 | $25.92 |
| P/E Ratio | ★ $186.33 | $1,251.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $32.21 |
| 52 Week High | $7.65 | $170.87 |
| Indicator | RXT | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 53.04 | 51.14 |
| Support Level | $1.04 | $32.21 |
| Resistance Level | $7.65 | $73.46 |
| Average True Range (ATR) | 0.79 | 3.66 |
| MACD | -0.11 | 1.81 |
| Stochastic Oscillator | 45.34 | 69.55 |
Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.